Introduction: Gliomas in the brain and the optic pathway affect up to 20% of all children with neurofibromatosis 1 (NF1); however, their frequency and natural history in adults is poorly described. Our objectives were to characterize the frequency and natural history of gliomas seen in NF1 patients by serial head magnetic resonance imaging (MRI) and to investigate associations between combined annotation-dependent depletion (CADD) scores and the presence of MRI features of NF1. Methods: 1775 head and whole-body MRI scans of 562 unselected NF1 patients were collected at the University Hospital Hamburg-Eppendorf in Hamburg, Germany. All scans were analyzed, and the frequency and natural history of gliomas was determined. In addition, the con...
Background Neurofibromatosis type 1 (NF1) affects 1 in 2500 people, and 15% of these may develop an ...
<p>Neurofibromatosis type I is a rare neurocutaneous syndrome resulting from loss-of-function mutati...
Background Neurofibromatosis type 1 (NF1) affects 1 in 2500 people, and 15% of these may develop an ...
Background: Optic pathway gliomas (OPGs) are present in 20% of children with neurof...
Abstract Background Optic pathway gliomas (OPGs) are present in 20% of children with neurofibromatos...
Background: Non-optic gliomas occur in 5% of children with NF1, but little is known...
AIM: Optic pathway gliomas (OPG) are the predominant intracranial tumours associated with neurofibro...
The aim of the study was to evaluate the importance of brain MRI's findings, and modify the criteria...
The aim of the study was to evaluate the importance of brain MRI's findings, and modify the criteria...
Neurofibromatosis type 1 (NF1) is a phenotypically heterogenous multisystem cancer predisposition sy...
Optic pathway gliomas (OPG) are the predominant intracranial tumours associated with neurofibromatos...
Optic pathway gliomas (OPG) are the predominant intracranial tumours associated with neurofibromatos...
Optic pathway gliomas (OPG) are the predominant intracranial tumours associated with neurofibromatos...
Neurofibromatosis type 1 (NF1) is a common genetic disorder with an incidence of 1:3000 births.1 Abo...
Background Neurofibromatosis type 1 (NF1) affects 1 in 2500 people, and 15% of these may develop an ...
Background Neurofibromatosis type 1 (NF1) affects 1 in 2500 people, and 15% of these may develop an ...
<p>Neurofibromatosis type I is a rare neurocutaneous syndrome resulting from loss-of-function mutati...
Background Neurofibromatosis type 1 (NF1) affects 1 in 2500 people, and 15% of these may develop an ...
Background: Optic pathway gliomas (OPGs) are present in 20% of children with neurof...
Abstract Background Optic pathway gliomas (OPGs) are present in 20% of children with neurofibromatos...
Background: Non-optic gliomas occur in 5% of children with NF1, but little is known...
AIM: Optic pathway gliomas (OPG) are the predominant intracranial tumours associated with neurofibro...
The aim of the study was to evaluate the importance of brain MRI's findings, and modify the criteria...
The aim of the study was to evaluate the importance of brain MRI's findings, and modify the criteria...
Neurofibromatosis type 1 (NF1) is a phenotypically heterogenous multisystem cancer predisposition sy...
Optic pathway gliomas (OPG) are the predominant intracranial tumours associated with neurofibromatos...
Optic pathway gliomas (OPG) are the predominant intracranial tumours associated with neurofibromatos...
Optic pathway gliomas (OPG) are the predominant intracranial tumours associated with neurofibromatos...
Neurofibromatosis type 1 (NF1) is a common genetic disorder with an incidence of 1:3000 births.1 Abo...
Background Neurofibromatosis type 1 (NF1) affects 1 in 2500 people, and 15% of these may develop an ...
Background Neurofibromatosis type 1 (NF1) affects 1 in 2500 people, and 15% of these may develop an ...
<p>Neurofibromatosis type I is a rare neurocutaneous syndrome resulting from loss-of-function mutati...
Background Neurofibromatosis type 1 (NF1) affects 1 in 2500 people, and 15% of these may develop an ...